Cargando…
Modifying dolutegravir to PrEPare for long life
Anti-retroviral therapy with drugs like dolutegravir is a powerful tool in both the treatment and prevention of HIV, but is limited by strict adherence to a daily therapeutic regimen. In a recent study, Deodhar, Sillman, and colleagues developed a dolutegravir prodrug that offers long-lasting protec...
Autor principal: | Mandarino, Angelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640719/ https://www.ncbi.nlm.nih.gov/pubmed/36344610 http://dx.doi.org/10.1038/s42003-022-04114-0 |
Ejemplares similares
-
778. PrEParing Medical Students For Their Transition to Residency: The Benefit of Early Education on HIV Prevention
por: Pavia, Jonathan E, et al.
Publicado: (2023) -
Getting youth PrEPared: adolescent consent laws and implications for the availability of PrEP among youth in countries outside of the United States
por: Taggart, Tamara, et al.
Publicado: (2019) -
1318. Are We PrEPared? Awareness and Prescribing Patterns of HIV Pre-Exposure Prophylaxis (PrEP) by Internal Medicine Resident Physicians at an Academic Medical Center
por: Hornak, J Patrik
Publicado: (2018) -
“How PrEPared are you?”: Knowledge of and attitudes toward PrEP among overseas-born and newly arrived gay, bisexual, and other men who have sex with men in Australia
por: Sudarto, Budiadi, et al.
Publicado: (2022) -
The PrEPARE Pretoria Project: protocol for a cluster-randomized factorial-design trial to prevent HIV with PrEP among adolescent girls and young women in Tshwane, South Africa
por: Wechsberg, Wendee M., et al.
Publicado: (2020)